rs11014504

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_201596.3(CACNB2):​c.334-3296T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.443 in 151,976 control chromosomes in the GnomAD database, including 15,194 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.44 ( 15194 hom., cov: 31)

Consequence

CACNB2
NM_201596.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.214

Publications

2 publications found
Variant links:
Genes affected
CACNB2 (HGNC:1402): (calcium voltage-gated channel auxiliary subunit beta 2) This gene encodes a subunit of a voltage-dependent calcium channel protein that is a member of the voltage-gated calcium channel superfamily. The gene product was originally identified as an antigen target in Lambert-Eaton myasthenic syndrome, an autoimmune disorder. Mutations in this gene are associated with Brugada syndrome. Alternatively spliced variants encoding different isoforms have been described. [provided by RefSeq, Feb 2013]
CACNB2 Gene-Disease associations (from GenCC):
  • Brugada syndrome 4
    Inheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, Laboratory for Molecular Medicine
  • Brugada syndrome 1
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • short QT syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.68 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_201596.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB2
NM_201596.3
MANE Select
c.334-3296T>C
intron
N/ANP_963890.2
CACNB2
NM_201590.3
MANE Plus Clinical
c.172-3296T>C
intron
N/ANP_963884.2
CACNB2
NM_201597.3
c.334-3296T>C
intron
N/ANP_963891.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB2
ENST00000324631.13
TSL:1 MANE Select
c.334-3296T>C
intron
N/AENSP00000320025.8
CACNB2
ENST00000377329.10
TSL:1 MANE Plus Clinical
c.172-3296T>C
intron
N/AENSP00000366546.4
CACNB2
ENST00000352115.10
TSL:1
c.334-3296T>C
intron
N/AENSP00000344474.6

Frequencies

GnomAD3 genomes
AF:
0.443
AC:
67249
AN:
151858
Hom.:
15197
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.415
Gnomad AMI
AF:
0.475
Gnomad AMR
AF:
0.420
Gnomad ASJ
AF:
0.386
Gnomad EAS
AF:
0.698
Gnomad SAS
AF:
0.490
Gnomad FIN
AF:
0.444
Gnomad MID
AF:
0.491
Gnomad NFE
AF:
0.443
Gnomad OTH
AF:
0.463
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.443
AC:
67267
AN:
151976
Hom.:
15194
Cov.:
31
AF XY:
0.444
AC XY:
32959
AN XY:
74288
show subpopulations
African (AFR)
AF:
0.415
AC:
17194
AN:
41446
American (AMR)
AF:
0.420
AC:
6417
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.386
AC:
1340
AN:
3470
East Asian (EAS)
AF:
0.699
AC:
3613
AN:
5170
South Asian (SAS)
AF:
0.489
AC:
2357
AN:
4820
European-Finnish (FIN)
AF:
0.444
AC:
4674
AN:
10524
Middle Eastern (MID)
AF:
0.483
AC:
142
AN:
294
European-Non Finnish (NFE)
AF:
0.443
AC:
30130
AN:
67954
Other (OTH)
AF:
0.457
AC:
968
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1904
3807
5711
7614
9518
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
632
1264
1896
2528
3160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.433
Hom.:
2558
Bravo
AF:
0.441
Asia WGS
AF:
0.533
AC:
1852
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
5.8
DANN
Benign
0.83
PhyloP100
0.21
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11014504; hg19: chr10-18783988; API